Scarab Genomics

Scarab Genomics

Biotechnology, 1202 Ann St, Madison, Wisconsin, 53713, United States, 11-50 Employees

scarabgenomics.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 60********

Who is SCARAB GENOMICS

Scarab Genomics, an emerging CMO, has created Clean Genome E. coli, a unique, patented set of bacterial hosts for reliable, high efficiency production of protein and nucleic acid biopharm...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SCARAB GENOMICS

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Scarab Genomics

Answer: Scarab Genomics's headquarters are located at 1202 Ann St, Madison, Wisconsin, 53713, United States

Answer: Scarab Genomics's phone number is 60********

Answer: Scarab Genomics's official website is https://scarabgenomics.com

Answer: Scarab Genomics's revenue is $1 Million to $5 Million

Answer: Scarab Genomics's SIC: 2834

Answer: Scarab Genomics's NAICS: 561110

Answer: Scarab Genomics has 11-50 employees

Answer: Scarab Genomics is in Biotechnology

Answer: Scarab Genomics contact info: Phone number: 60******** Website: https://scarabgenomics.com

Answer: Scarab Genomics, an emerging CMO, has created Clean Genome E. coli, a unique, patented set of bacterial hosts for reliable, high efficiency production of protein and nucleic acid biopharmaceuticals. All troublesome genetic elements, inlcuding IS elements and cryptic phages, and many nonessential genes, have been removed from the genome, resulting in more efficient and more reliable production. Benefits include reduced mutational damage to vectors and products, elimination of contamination of nucleic acid vaccines with IS elements, and prevention of loss of fermentation batches due to phage induction. Current licensees use these hosts for production of proteins and DNA vaccines. Clean Genome E. coli is, unlike other hosts, capable of continuous production, which has been implemented as C-FlowTM. A typical 30-day C-FlowTM process yields 4.5 kg protein per month before purification at a mere 10-liter scale, dramatically reducing infrastructure requirements for substantial production volumes. Because production is continuous, conditions can be optimized on the fly, and because volumes are small, scale-up is rapid. As a result process development is rapid, enabling quick responses to pandemics such as Covid-19 and to bioterrorism. At even 1-L scale C-FlowTM can efficiently address needs for orphan drugs and personalized medicine. Enabled by reduced genome strains, we sell research grade vaccine carrier proteins CRM197 and Protein D, and are developing continuous cGMP manufacturing of CRM197 for clinical needs. Scarab offers licensing options for research and for commercial production. Clients may license Clean Genome strains customized for specific applications using their existing production infrastructure, or the full C-FlowTM continuous fermentation system for maximum efficiency.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access